Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study.
Identifieur interne : 003458 ( Main/Exploration ); précédent : 003457; suivant : 003459Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study.
Auteurs : Mehmet Kurkcu [Turquie] ; M Emre Benlidayi ; Burcu Cam ; Yasar SertdemirSource :
- The Journal of oral implantology [ 0160-6972 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Animaux, Bovins, Femelle, Humains, Hydroxyapatites (usage thérapeutique), Matériaux biocompatibles (), Matériaux biocompatibles (usage thérapeutique), Maxillaire (), Maxillaire (anatomopathologie), Minéraux (usage thérapeutique), Mâchoire partiellement édentée (), Mâchoire édentée (), Mâle, Ostéo-intégration (), Ostéogenèse (), Phosphates de calcium (usage thérapeutique), Pose d'implant dentaire endo-osseux (), Pose d'implant dentaire endo-osseux (instrumentation), Rehaussement du plancher du sinus (), Résultat thérapeutique, Sinus maxillaire (), Substituts osseux (), Substituts osseux (usage thérapeutique).
- MESH :
- anatomopathologie : Maxillaire.
- usage thérapeutique : Hydroxyapatites, Matériaux biocompatibles, Minéraux, Phosphates de calcium, Pose d'implant dentaire endo-osseux, Substituts osseux.
- Adulte, Adulte d'âge moyen, Animaux, Bovins, Femelle, Humains, Matériaux biocompatibles, Maxillaire, Mâchoire partiellement édentée, Mâchoire édentée, Mâle, Ostéo-intégration, Ostéogenèse, Pose d'implant dentaire endo-osseux, Rehaussement du plancher du sinus, Résultat thérapeutique, Sinus maxillaire, Substituts osseux.
English descriptors
- KwdEn :
- Adult, Animals, Biocompatible Materials (chemistry), Biocompatible Materials (therapeutic use), Bone Substitutes (chemistry), Bone Substitutes (therapeutic use), Calcium Phosphates (therapeutic use), Cattle, Dental Implantation, Endosseous (instrumentation), Dental Implantation, Endosseous (methods), Female, Humans, Hydroxyapatites (therapeutic use), Jaw, Edentulous (surgery), Jaw, Edentulous, Partially (surgery), Male, Maxilla (pathology), Maxilla (surgery), Maxillary Sinus (surgery), Middle Aged, Minerals (therapeutic use), Osseointegration (drug effects), Osteogenesis (drug effects), Sinus Floor Augmentation (methods), Treatment Outcome.
- MESH :
- chemical , chemistry : Biocompatible Materials, Bone Substitutes.
- chemical , therapeutic use : Biocompatible Materials, Bone Substitutes, Calcium Phosphates, Hydroxyapatites, Minerals.
- drug effects : Osseointegration, Osteogenesis.
- instrumentation : Dental Implantation, Endosseous.
- methods : Dental Implantation, Endosseous, Sinus Floor Augmentation.
- pathology : Maxilla.
- surgery : Jaw, Edentulous, Jaw, Edentulous, Partially, Maxilla, Maxillary Sinus.
- Adult, Animals, Cattle, Female, Humans, Male, Middle Aged, Treatment Outcome.
Abstract
The choice of augmentation material is a crucial factor in sinus augmentation surgery. Bovine-derived hydroxyapatite (BHA) and beta-tricalcium phosphate (β-TCP) have been used successfully in sinus augmentation procedures. Choosing one of these materials for sinus augmentation is still controversial. The aim of this clinical study was to compare the biological performance of the new BHA graft material and the well-known synthetic β-TCP material in the sinus augmentation procedure. The study consisted of 23 patients (12 male and 11 female) who were either edentulous or partially edentulous in the posterior maxilla and required implant placement. A total of 23 two-step sinus-grafting procedures were performed. BHA was used in 13 patients, and β-TCP was used in 10 patients. After an average of 6.5 months of healing, bone biopsies were taken from the grafted areas. Undecalcified sections were prepared for histomorphometric analysis. The mean new bone formation was 30.13% ± 3.45% in the BHA group and 21.09% ± 2.86% in the β-TCP group (P = .001). The mean percentage of residual graft particle area was 31.88% ± 6.05% and 34.05% ± 3.01% for the BHA group and β-TCP group, respectively (P = .047). The mean percentage of soft-tissue area was 37.99% ± 5.92% in the BHA group and 44.86% ± 4.28% in the β-TCP group (P = .011). Both graft materials demonstrated successful biocompatibility and osteoconductivity in the sinus augmentation procedure. However, BHA appears to be more efficient in osteoconduction when compared with β-TCP.
DOI: 10.1563/AAID-JOI-D-11-00061
PubMed: 23072285
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000F66
- to stream PubMed, to step Curation: 000F66
- to stream PubMed, to step Checkpoint: 000F66
- to stream Ncbi, to step Merge: 004201
- to stream Ncbi, to step Curation: 004201
- to stream Ncbi, to step Checkpoint: 004201
- to stream Main, to step Merge: 003475
- to stream Main, to step Curation: 003458
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study.</title><author><name sortKey="Kurkcu, Mehmet" sort="Kurkcu, Mehmet" uniqKey="Kurkcu M" first="Mehmet" last="Kurkcu">Mehmet Kurkcu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cukurova University, Adana, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cukurova University, Adana</wicri:regionArea><wicri:noRegion>Adana</wicri:noRegion></affiliation></author><author><name sortKey="Benlidayi, M Emre" sort="Benlidayi, M Emre" uniqKey="Benlidayi M" first="M Emre" last="Benlidayi">M Emre Benlidayi</name></author><author><name sortKey="Cam, Burcu" sort="Cam, Burcu" uniqKey="Cam B" first="Burcu" last="Cam">Burcu Cam</name></author><author><name sortKey="Sertdemir, Yasar" sort="Sertdemir, Yasar" uniqKey="Sertdemir Y" first="Yasar" last="Sertdemir">Yasar Sertdemir</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23072285</idno><idno type="pmid">23072285</idno><idno type="doi">10.1563/AAID-JOI-D-11-00061</idno><idno type="wicri:Area/PubMed/Corpus">000F66</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F66</idno><idno type="wicri:Area/PubMed/Curation">000F66</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F66</idno><idno type="wicri:Area/PubMed/Checkpoint">000F66</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F66</idno><idno type="wicri:Area/Ncbi/Merge">004201</idno><idno type="wicri:Area/Ncbi/Curation">004201</idno><idno type="wicri:Area/Ncbi/Checkpoint">004201</idno><idno type="wicri:doubleKey">0160-6972:2012:Kurkcu M:anorganic:bovine:derived</idno><idno type="wicri:Area/Main/Merge">003475</idno><idno type="wicri:Area/Main/Curation">003458</idno><idno type="wicri:Area/Main/Exploration">003458</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study.</title><author><name sortKey="Kurkcu, Mehmet" sort="Kurkcu, Mehmet" uniqKey="Kurkcu M" first="Mehmet" last="Kurkcu">Mehmet Kurkcu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cukurova University, Adana, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Cukurova University, Adana</wicri:regionArea><wicri:noRegion>Adana</wicri:noRegion></affiliation></author><author><name sortKey="Benlidayi, M Emre" sort="Benlidayi, M Emre" uniqKey="Benlidayi M" first="M Emre" last="Benlidayi">M Emre Benlidayi</name></author><author><name sortKey="Cam, Burcu" sort="Cam, Burcu" uniqKey="Cam B" first="Burcu" last="Cam">Burcu Cam</name></author><author><name sortKey="Sertdemir, Yasar" sort="Sertdemir, Yasar" uniqKey="Sertdemir Y" first="Yasar" last="Sertdemir">Yasar Sertdemir</name></author></analytic><series><title level="j">The Journal of oral implantology</title><idno type="ISSN">0160-6972</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Animals</term><term>Biocompatible Materials (chemistry)</term><term>Biocompatible Materials (therapeutic use)</term><term>Bone Substitutes (chemistry)</term><term>Bone Substitutes (therapeutic use)</term><term>Calcium Phosphates (therapeutic use)</term><term>Cattle</term><term>Dental Implantation, Endosseous (instrumentation)</term><term>Dental Implantation, Endosseous (methods)</term><term>Female</term><term>Humans</term><term>Hydroxyapatites (therapeutic use)</term><term>Jaw, Edentulous (surgery)</term><term>Jaw, Edentulous, Partially (surgery)</term><term>Male</term><term>Maxilla (pathology)</term><term>Maxilla (surgery)</term><term>Maxillary Sinus (surgery)</term><term>Middle Aged</term><term>Minerals (therapeutic use)</term><term>Osseointegration (drug effects)</term><term>Osteogenesis (drug effects)</term><term>Sinus Floor Augmentation (methods)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Bovins</term><term>Femelle</term><term>Humains</term><term>Hydroxyapatites (usage thérapeutique)</term><term>Matériaux biocompatibles ()</term><term>Matériaux biocompatibles (usage thérapeutique)</term><term>Maxillaire ()</term><term>Maxillaire (anatomopathologie)</term><term>Minéraux (usage thérapeutique)</term><term>Mâchoire partiellement édentée ()</term><term>Mâchoire édentée ()</term><term>Mâle</term><term>Ostéo-intégration ()</term><term>Ostéogenèse ()</term><term>Phosphates de calcium (usage thérapeutique)</term><term>Pose d'implant dentaire endo-osseux ()</term><term>Pose d'implant dentaire endo-osseux (instrumentation)</term><term>Rehaussement du plancher du sinus ()</term><term>Résultat thérapeutique</term><term>Sinus maxillaire ()</term><term>Substituts osseux ()</term><term>Substituts osseux (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Biocompatible Materials</term><term>Bone Substitutes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Biocompatible Materials</term><term>Bone Substitutes</term><term>Calcium Phosphates</term><term>Hydroxyapatites</term><term>Minerals</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Maxillaire</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Osseointegration</term><term>Osteogenesis</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Dental Implantation, Endosseous</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Dental Implantation, Endosseous</term><term>Sinus Floor Augmentation</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Maxilla</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Jaw, Edentulous</term><term>Jaw, Edentulous, Partially</term><term>Maxilla</term><term>Maxillary Sinus</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Hydroxyapatites</term><term>Matériaux biocompatibles</term><term>Minéraux</term><term>Phosphates de calcium</term><term>Pose d'implant dentaire endo-osseux</term><term>Substituts osseux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Animals</term><term>Cattle</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Bovins</term><term>Femelle</term><term>Humains</term><term>Matériaux biocompatibles</term><term>Maxillaire</term><term>Mâchoire partiellement édentée</term><term>Mâchoire édentée</term><term>Mâle</term><term>Ostéo-intégration</term><term>Ostéogenèse</term><term>Pose d'implant dentaire endo-osseux</term><term>Rehaussement du plancher du sinus</term><term>Résultat thérapeutique</term><term>Sinus maxillaire</term><term>Substituts osseux</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The choice of augmentation material is a crucial factor in sinus augmentation surgery. Bovine-derived hydroxyapatite (BHA) and beta-tricalcium phosphate (β-TCP) have been used successfully in sinus augmentation procedures. Choosing one of these materials for sinus augmentation is still controversial. The aim of this clinical study was to compare the biological performance of the new BHA graft material and the well-known synthetic β-TCP material in the sinus augmentation procedure. The study consisted of 23 patients (12 male and 11 female) who were either edentulous or partially edentulous in the posterior maxilla and required implant placement. A total of 23 two-step sinus-grafting procedures were performed. BHA was used in 13 patients, and β-TCP was used in 10 patients. After an average of 6.5 months of healing, bone biopsies were taken from the grafted areas. Undecalcified sections were prepared for histomorphometric analysis. The mean new bone formation was 30.13% ± 3.45% in the BHA group and 21.09% ± 2.86% in the β-TCP group (P = .001). The mean percentage of residual graft particle area was 31.88% ± 6.05% and 34.05% ± 3.01% for the BHA group and β-TCP group, respectively (P = .047). The mean percentage of soft-tissue area was 37.99% ± 5.92% in the BHA group and 44.86% ± 4.28% in the β-TCP group (P = .011). Both graft materials demonstrated successful biocompatibility and osteoconductivity in the sinus augmentation procedure. However, BHA appears to be more efficient in osteoconduction when compared with β-TCP.</div></front></TEI><affiliations><list><country><li>Turquie</li></country></list><tree><noCountry><name sortKey="Benlidayi, M Emre" sort="Benlidayi, M Emre" uniqKey="Benlidayi M" first="M Emre" last="Benlidayi">M Emre Benlidayi</name><name sortKey="Cam, Burcu" sort="Cam, Burcu" uniqKey="Cam B" first="Burcu" last="Cam">Burcu Cam</name><name sortKey="Sertdemir, Yasar" sort="Sertdemir, Yasar" uniqKey="Sertdemir Y" first="Yasar" last="Sertdemir">Yasar Sertdemir</name></noCountry><country name="Turquie"><noRegion><name sortKey="Kurkcu, Mehmet" sort="Kurkcu, Mehmet" uniqKey="Kurkcu M" first="Mehmet" last="Kurkcu">Mehmet Kurkcu</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003458 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003458 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23072285
|texte= Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23072285" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |